Articles related to DRUG SAFETY & INTERACTIONS

Recent research indicates that pharmaceutical nitrosamine contamination presents broader implications for drug safety, with increasing evidence of genotoxic and mutagenic effects even at trace levels.

Manufacturing violations at an Indian facility have triggered a recall of 15 million OTC pain patches, raising concerns about product quality and patient safety across multiple widely-used brands.

Medication-induced ocular complications can occur across multiple drug classes, with risk factors including dosage, duration of treatment, and individual patient susceptibility.

Anticholinergic medications require careful consideration of both peripheral and central effects, particularly in patients with existing cognitive impairments.

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.

Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.